SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-23-000371
Filing Date
2023-10-19
Accepted
2023-10-19 16:48:44
Documents
1
Group Members
AKRATI AGARWALALKA SOODANESHA AGARWALANITA JAINBINA PATELDIWAKAR JAININDU R. GUPTAJATIN PATELKRISHNAN NANDABALANKRUNAL PATELMARSHAL D. GIBSONMICHAEL AIELLOPARDEEP SOODRASHMI AGARWALSUGANTHI BALASUBRAMANIANTARUN K. GUPTAVIPIN AGARWAL

Document Format Files

Seq Description Document Type Size
1 SC 13G/A bioxcel_13ga6.htm SC 13G/A 224255
  Complete submission text file 0001019056-23-000371.txt   226235
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90437 | Film No.: 231335201
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2614 BOSTON POST ROAD, SUITE 33B GUILFORD CT 06437
Business Address 2614 BOSTON POST ROAD, SUITE 33B GUILFORD CT 06437 203-643-8060
BioXcel Holdings, Inc. (Filed by) CIK: 0001811154 (see all company filings)

IRS No.: 850849560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A